These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28641048)

  • 1. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
    Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
    Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status on microRNAs as biomarkers for ovarian cancer.
    Prahm KP; Novotny GW; Høgdall C; Høgdall E
    APMIS; 2016 May; 124(5):337-55. PubMed ID: 26809719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
    Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
    Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of miRNA in Ovarian Cancer: an Overview.
    Zhao L; Liang X; Wang L; Zhang X
    Reprod Sci; 2022 Oct; 29(10):2760-2767. PubMed ID: 34973152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs and ovarian cancer: An overview.
    Deb B; Uddin A; Chakraborty S
    J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs as biomarkers of ovarian cancer.
    Zhang H; Lu B
    Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Hasanzadeh M; Parizadeh SMR; Hassanian SM; Rezaei-Kalat A; Aghabozorgi AS; Rahimi-Kakhki R; Zargaran B; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(14):1447-1460. PubMed ID: 31284859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.
    El Bairi K; Kandhro AH; Gouri A; Mahfoud W; Louanjli N; Saadani B; Afqir S; Amrani M
    Cell Oncol (Dordr); 2017 Apr; 40(2):105-118. PubMed ID: 27981507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
    Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
    Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.
    Gasparri ML; Casorelli A; Bardhi E; Besharat AR; Savone D; Ruscito I; Farooqi AA; Papadia A; Mueller MD; Ferretti E; Benedetti Panici P
    Tumour Biol; 2017 May; 39(5):1010428317695525. PubMed ID: 28459207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
    Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
    Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
    Robotti M; Scebba F; Angeloni D
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
    Smith B; Agarwal P; Bhowmick NA
    Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wu L; Shang W; Zhao H; Rong G; Zhang Y; Xu T; Zhang J; Huang P; Wang F
    Dis Markers; 2019; 2019():7541857. PubMed ID: 31467618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.